Merck joins obesity pill race with up to $2B Hansoh deal

Merck joins obesity pill race with up to $2B Hansoh deal

Submitted by admin on December 18, 2024 - 11:18am
Source: 
BioSpace
News Tags: 
Merck
obesity
China
Hansoh
GLP-1 agonists
Headline: 
Merck joins obesity pill race with up to $2B Hansoh deal
snippet: 

The Hansoh deal will let Merck compete in the crowded oral GLP-1 space alongside fellow pharma giants Eli Lilly, Novo Nordisk and Roche.

Do Not Allow Advertisers to Use My Personal information